Metraipolis › archive › dc_4bd6ca3b2b2e
The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China — Europe PMC PMID:34488801
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/34488801
- DOI
- 10.1186/s12992-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T20:44:42.322Z
- SHA-256 of the archived text
49e267148acda589d7f58c5b89f47a534a99c63719dba08db297a6b766facd14- Stable URL of this page
https://metraipolis.com/documento/dc_4bd6ca3b2b2e
How to cite
The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China — Europe PMC PMID:34488801 — Europe PMC (en), https://europepmc.org/article/MED/34488801 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bd6ca3b2b2e (Metraipolis archive dc_4bd6ca3b2b2e, sha256 49e267148acda589d7f58c5b89f47a534a99c63719dba08db297a6b766facd14)
BibTeX
@misc{dc4bd6ca3b2b2e,
title = {The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China — Europe PMC PMID:34488801},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/34488801},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bd6ca3b2b2e; sha256 49e267148acda589d7f58c5b89f47a534a99c63719dba08db297a6b766facd14},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/34488801. Agents can read the archived copy with the MCP tool read_document.